Return Goods Policy

Please note that there are product-specific exceptions outlined in our Returns Policy. Modifications to the policy are updated regularly and can be viewed here. It is recommended that you review the policy prior to sending product back for returns.

Current exceptions include:

• Activase/TNKase for hospitals: Replacement (*Does not apply to Cathflo Activase)
• SUSVIMO initial fill needle kit (NDC 50242-078-55) Backup Returns Window Exception
• Xofluza Lots: Returns window exception

Actemra Exceptions:

• IV product purchased before August 2022 is NOT eligible for return since it was sold under a non-returnable basis (see exception below) even if product is now expired
• IV product purchased after August 2022 is now eligible for return if expired
• Exception: ACTEMRA (Tocilizumab) 400 mg / 20 mL (NDC 50242-137-01) with the dark colored vial cap is eligible

General Policy Guidelines:

• We accept expired product from 2 months before the expiration date listed on the product to 6 months after the expiration date listed on the product.
• The expiration date is the last day of the month listed on the product.
• Product must be returned in its original packaging.

Timelines:

• We will send out a replacement after receiving verification from Qualanex that they have received and processed the product return.
• In general Qualanex processes product within 11 business days of receipt at their facility.
• If there is an urgent patient need please contact Genentech Customer Service at (800) 551-2231 for support.

How to return Genentech product to Qualanex:

If you have not previously sent product to Qualanex for the returns program, please click here to access how-to return instructions.